Logo of Phnom Penh Post newspaper Phnom Penh Post - Two Ebola drugs found to add survival rates in a clinical trial

Two Ebola drugs found to add survival rates in a clinical trial

Content image - Phnom Penh Post
A girl receives a vaccine against Ebola from a nurse in Goma on August 7. AUGUSTIN WAMENYA/AFP

Two Ebola drugs found to add survival rates in a clinical trial

Scientists were a step closer to an effective treatment for Ebola after two drugs in a clinical trial were found to significantly boost survival rates, the US health authority co-funding the research said on Monday.

The study began last November in the Democratic Republic of Congo, but its current phase has been halted and all future patients switched over to the treatments that have shown positive results, the US National Institutes of Health (NIH) said in a statement.

REGN-EB3 and mAb114 “are the first drugs that, in a scientifically sound study, have clearly shown a significant diminution in mortality for people with Ebola virus disease,” said Anthony Fauci, director of the NIH’s National Institute of Allergy and Infectious Diseases.

Patients who were receiving two other drugs that are being discontinued, Zmapp and remdesivir, will now have the option at the discretion of their treating physician to receive the treatments that have been shown to work.

Fauci explained that the trial was designed to include 725 people, but was halted by an independent board when it had enrolled 681 people because at that point, one of the drugs, REGN-EB3 by Regeneron, reached a critical threshold in success, while mAb114 was not far behind.

Data has so far been analysed for 499 people from the cohort of 681.

In this group, mortality dropped to 29 per cent with REGN-EB3 and with mAb114 it fell to 34 per cent, said Fauci – compared to a rate of between 60 and 67 per cent in the general population when the disease is not treated by a drug.

The rates for Zmapp and remdesivir were 49 per cent and 53 per cent respectively.

REGN-EB3, mAb114 and Zmapp are monoclonal antibodies that bind to glycoprotein on the Ebola virus and neutralise its ability to infect other cells.

Fauci added that the final analysis of the data, including the patients not yet processed, would occur in late September or early October, after which the complete results would be submitted for publication in peer-reviewed medical literature.

The NIH, Democratic Republic of Congo health authorities and the World Health Organisation hailed the “extraordinary team of individuals who have worked under extremely difficult conditions to carry out this study,” as well as the patients and their families.

Jeremy Farrar, director of Britain’s Wellcome Trust research charity, said the development would “undoubtedly save lives”, adding: “Thanks to this trial, we are starting to understand which treatments to offer to patients in this and future outbreaks.”

More than 1,800 people have died in eastern Democratic Republic of Congo since Ebola broke out there in August last year.

The virus is transmitted to people from wild animals, then spreads among humans through direct contact with the blood or other secretions of infected people or with surfaces contaminated with their fluids, according to the World Health Organisation.

The latest trial demonstrates “you can dramatically diminish the mortality”, said Fauci, “but getting rid of the Ebola virus becomes a [case of] prevention, of how you could prevent this from spreading”.

“The best way to end the outbreak is with a good vaccine, as well as to do good contact tracing, isolation, and then, ultimately, treatment.”

Health authorities are currently investigating several vaccine candidates.

MOST VIEWED

  • Bareknuckle champion wants Kun Khmer fighter

    Dave Leduc, who is the current openweight Lethwei boxing champion in Myanmar, has announced that he will travel to Cambodia this year to challenge SEA Games gold medallist Prum Samnang any time that is convenient, after their planned match later this month in Slovakia was

  • Five-year-old Hanuman dances his way into hearts of Cambodia

    A young talent from a new-established settlement has emerged, captivating the online world with his mesmerising performances of the traditional Cambodian monkey dance. Roeun Kakada is a five-year-old prodigy who has taken the social media sphere by storm with his exceptional dance skills and dedication

  • Fresh Covid warnings as Thai hospital fills

    A senior health official reminds the public to remain vigilant, as neighbouring countries experience an increase in Covid-19 cases, with the latest surge appearing to be a result of the Omicron XBB.1.5 sub-variant. Or Vandine, secretary of state and spokeswoman for the Ministry of Health,

  • Honda shutters Siem Reap football club

    Japanese football legend Keisuke Honda, the owner of Siem Reap football club Soltilo Angkor FC, has been forced to shut the club down, after it failed to attract sponsorship for the upcoming season. Honda, the former manager of the Cambodia men's national football team, said

  • Hun Sen warns of regional tensions

    ASIA is becoming a dangerous geopolitical hotspot, with several countries announcing that they intend to send naval vessels towards Southeast Asia and on to the South China Sea, warned Prime Minister Hun Sen. “Heated geopolitical issues can easily escalate, namely to war. I am not

  • PM declares ASEAN Para Games open

    The 12th ASEAN Para Games officially kicked off on the evening of June 3 at Morodok Techo National Stadium in Phnom Penh, with a spectacular opening ceremony featuring fireworks and performances by some of the Kingdom’s most accomplished talents. Tens of thousands of sports fans